Transaction · 0001622058-26-000008

Troendle August J.

Troendle August J., PRES, CEO, reported an open-market or private sale at Medpace Holdings, Inc. involving 4000.000000 shares for an estimated $2480120.00. Reported holdings after the transaction were 540544.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SPRES, CEO
MEDPMedpace Holdings, Inc.
Trade date
Aug 26, 2026
Filing date
Aug 27, 2026
View on SEC Insider profile
Estimated value-$2.48MShares × reported price
Shares traded4.00k$620.03 per share
Holdings after540kDirect
% of reported position traded0.73%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 544,544 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

MEDP price since this filing

Daily closing prices, with the filing date and available return windows
MEDP · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -3.6%1w ago -0.5%1d ago -0.0%
Returns since7d -3.0%30d +1.2%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001622058-26-000008
Common Stock
Transaction date
Aug 26, 2026
Filed Aug 27, 2026, 08:12 PM · 1d delay
Shares
4,000 sh
$620.03 per share
Estimated value
-$2.48M
Computed from shares × price
Holdings after
540,544 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Cluster Selling Direct Ownership Large Sale Repeat Seller
Filing-only score

+10 points

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 1

    Filing reported within two business days of the transaction.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

President & CEO

Officer YesDirector Yes10% YesOther No
Footnotes & amended
  1. F1

    The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

  2. F2

    The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $620.00 to $621.89. The Reporting Person undertakes to provide full pricing information to…

  3. F3

    The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $620.00 to $620.54. The Reporting Person undertakes to provide full pricing information t…

  4. F4

    The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Report…

Original filing · 0001622058-26-000008
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

MEDP